What is the management of shock in a newborn?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Shock in Newborns

Immediate aggressive fluid resuscitation with 10 mL/kg isotonic crystalloid boluses up to 60 mL/kg within the first 5 minutes, followed by dopamine (5-9 mcg/kg/min) plus dobutamine (up to 10 mcg/kg/min) if shock persists at 15 minutes, then escalation to epinephrine (0.05-0.3 mcg/kg/min) by 60 minutes if unresponsive—this time-sensitive algorithmic approach reduces mortality in neonatal septic shock. 1

Initial Recognition and Stabilization (0-5 Minutes)

Recognize shock immediately by identifying decreased perfusion, poor tone, poor color, tachypnea, respiratory distress, or cyanosis—do not wait for hypotension as newborns maintain blood pressure until late decompensated shock. 1

  • Maintain airway according to NRP guidelines and begin high-flow oxygen 1
  • Establish IV or intraosseous access immediately 1
  • Start prostaglandin infusion until ductal-dependent congenital heart disease is ruled out—any newborn with shock plus hepatomegaly, cyanosis, cardiac murmur, or differential upper/lower extremity pulses requires prostaglandin until echocardiography excludes complex congenital heart disease 1
  • Measure preductal and postductal oxygen saturations—a difference >5% indicates right-to-left shunting through the ductus arteriosus, suggesting persistent pulmonary hypertension of the newborn (PPHN) 1, 2

Fluid Resuscitation (First 5 Minutes)

Administer 10 mL/kg boluses of isotonic saline or colloid, repeating up to 60 mL/kg total until perfusion improves—stop only if hepatomegaly develops, indicating fluid overload. 1

  • Use crystalloid if hemoglobin >12 g/dL; transfuse packed red blood cells if hemoglobin <12 g/dL 1
  • Correct hypoglycemia with D10%-containing isotonic IV solution at maintenance rate 1
  • Correct hypocalcemia immediately 1
  • Begin empiric antibiotics within 5 minutes unless rales or hepatomegaly develop 1

Critical pitfall: Unlike older children who may require 20 mL/kg boluses, newborns receive smaller 10 mL/kg boluses due to immature myocardial compliance, but total volume up to 60 mL/kg may still be necessary. 1

Fluid-Refractory Shock (15 Minutes)

If shock persists after adequate fluid resuscitation:

Start dopamine 5-9 mcg/kg/min plus dobutamine up to 10 mcg/kg/min as first-line inotropic therapy. 1

  • Dopamine is superior for improving blood pressure in hypotensive infants 3
  • Dobutamine improves systemic blood flow, especially in very low birth weight infants 3
  • Do not use high-dose dopamine (>10 mcg/kg/min) as it increases pulmonary vascular resistance and worsens PPHN 2
  • Obtain central venous access if not already established 1
  • Consider intubation and mechanical ventilation if work of breathing is excessive 1

Catecholamine-Resistant Shock (60 Minutes)

Escalate to epinephrine 0.05-0.3 mcg/kg/min if shock persists despite dopamine/dobutamine. 1, 4

  • Epinephrine provides both alpha and beta-adrenergic stimulation, increasing vascular tone and cardiac output 5
  • Monitor for tachyarrhythmias and excessive vasoconstriction 1
  • Add hydrocortisone if absolute adrenal insufficiency is suspected—defined as peak cortisol after ACTH <18 μg/dL, or basal cortisol <18 μg/dL in an appropriately volume-loaded patient requiring epinephrine 1
  • Monitor central venous pressure and target ScvO2 >70% 1

PPHN-Specific Management

If preductal-postductal oxygen saturation differential >5% or echocardiography confirms PPHN:

  • Start inhaled nitric oxide (iNO) at 20 ppm immediately—this is first-line therapy for PPHN and improves oxygenation by selective pulmonary vasodilation 1, 2
  • Optimize lung recruitment with mechanical ventilation as this is critical for iNO efficacy 2
  • Target >95% arterial oxygen saturation and <5% preductal-postductal gradient 1, 2
  • In newborns with poor left ventricular function and normal blood pressure, add nitrosovasodilators or type III phosphodiesterase inhibitors (milrinone) to epinephrine—but volume load carefully when using systemic vasodilators 1

Very Low Birth Weight Infants

Administer IV pentoxifylline (5-day course, 6 hours per day) to reverse septic shock in VLBW babies. 1

Refractory Shock Management

Rule out reversible causes before escalating to ECMO:

  • Pericardial effusion (perform pericardiocentesis) 1
  • Pneumothorax (perform thoracentesis) 1
  • Ongoing blood loss (replace blood and achieve hemostasis) 1
  • Hypothyroidism (administer triiodothyronine) 1
  • Inborn errors of metabolism (treat with glucose and insulin infusion or ammonia scavengers) 1
  • Hemodynamically significant patent ductus arteriosus (consider closure) 1

Consider advanced hemodynamic monitoring with echocardiography, Doppler ultrasound, or measurement of superior vena cava (SVC) flow to guide therapy—target SVC flow >40 mL/kg/min and cardiac index >3.3 L/min/m². 1

Rescue vasopressors: Norepinephrine can be effective for refractory hypotension but ScvO2 must be maintained >70%—add additional inotrope if needed. 1 Vasopressin, terlipressin, or angiotensin can be considered only with adequate cardiac output and ScvO2 monitoring. 1

ECMO Indications

Consider ECMO when refractory shock persists despite maximal medical therapy or PaO2 <40 mmHg—current ECMO survival rate for newborn sepsis is 80%. 1

  • ECMO flows >110 mL/kg/min should be avoided due to hemolysis risk 1
  • Normalize calcium concentration in red blood cell pump prime (300 mg CaCl2 per unit of packed red blood cells) 1
  • With veno-venous ECMO, persistent hypotension requires dopamine/dobutamine or epinephrine 1
  • If fluid overload >10% develops despite diuretics, perform continuous renal replacement therapy (CRRT) on the ECMO circuit 1

Therapeutic Endpoints

Target the following goals to ensure adequate tissue perfusion:

  • Capillary refill ≤2 seconds 1, 2
  • Normal pulses without differential between peripheral and central 1
  • Warm extremities 1
  • Urine output >1 mL/kg/hr 1
  • Normal mental status 1
  • Normal blood pressure for age 1
  • 95% arterial oxygen saturation 1

  • <5% difference in preductal and postductal oxygen saturation 1, 2
  • ScvO2 >70% 1
  • SVC flow >40 mL/kg/min 1
  • Cardiac index >3.3 L/min/m² 1, 6, 2

Monitoring Requirements

Continuous monitoring should include: preductal and postductal pulse oximetry, intra-arterial blood pressure (umbilical or peripheral), electrocardiogram, temperature, glucose and calcium concentrations, fluid balance, urine output, central venous pressure/oxygen saturation, cardiac output or SVC flow, INR, anion gap, and lactate. 1

Common Pitfalls

  • Do not delay epinephrine if dopamine/dobutamine is ineffective—prolonged trials of inadequate therapy increase mortality 2
  • Do not administer excessive fluid boluses in the absence of hypovolemia—myocardial dysfunction is common in extremely preterm infants and term infants with perinatal asphyxia, and excessive fluids worsen outcomes 3, 7
  • Do not use diuretics in hypovolemic shock—diuretics are indicated only in hypervolemic patients with >10% fluid overload who cannot achieve fluid balance 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Critically Unstable Infant with Suspected PPHN

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of Shock in Neonates.

Indian journal of pediatrics, 2015

Guideline

Management of Refractory Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Shock Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.